- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01102881
Laxation and Satiety Response of Novel Dietary Fibers
September 8, 2010 updated by: University of Minnesota
Dietary fibers have previously been shown to affect laxation and satiety.
Due to differences in structure and physical properties of dietary fibers, these effects may not be consistent across all fibers.
Therefore as new dietary fibers are created or discovered the laxative and satiating effects should be investigated in order to verify these effects.
Study Overview
Status
Completed
Conditions
Detailed Description
This study was designed to test the laxative effects of two fibers a resistant starch made from corn and a glucose polymer fiber.
The secondary aim of this study was to examine the satieting effects of these fibers.
This trial was double-blind and placebo controlled.
On the first day of the study subjects consumed the breakfast cereal and milk and were instructed to complete visual analog scales periodically to test acute satiety.
Subjects also completed diet records and tolerance questionnaires on days 1,2, and 10.
Additionally subjects completed another satiety survey on day 10 to test chronic satiety.
Whole gut transit time, fecal weight, and fecal chemistry was tested by swallowing radioopaque pellets on day 6 and collecting every fecal sample for the 5 days thereafter.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
St. Paul, Minnesota, United States, 55108
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 61 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy men and women
- age 18-65
- non-smoking
- not taking medication
- non-dieting (weight stable in prior 3 months)
- BMI 18-30
- English literacy
Exclusion Criteria:
- do not regularly consume breakfast
- food allergies to ingredients found in study product
- dislike of cereal or muffins
- BMI <18 or >30
- diagnosed with cardiovascular, renal, or hepatic disease
- diabetes mellitus (fasting blood glucose > 126 mg/ml)
- cancer in previous 5 years (except basal cell carcinoma of the skin)
- any gastrointestinal disease or condition
- recent bacterial infection (< 3 months)
- recent or concurrent participation in an intervention research study
- history of drug or alcohol abuse in prior 6 months
- use of lipid-lowering, anti-hypertensive, or anti-inflammatory steroid medications vegetarians people who eat more than approximately 15 grams of dietary fiber per day women who are pregnant or lactating women with irregular menstrual cycles consumption of prebiotics or probiotics
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: No fiber
No fiber added to muffins or cereal
|
low fiber breakfast cereal and muffin
|
|
Experimental: Fiber made from corn starch
Muffins and cereal made with novel corn fiber
|
20 grams of fiber per day split into two 10 gram doses administered as a breakfast cereal and a muffin or no-fiber breakfast cereal and muffin
Other Names:
|
|
Experimental: Glucose polymer fiber
Muffins and cereal made from glucose polymer fiber
|
20 grams of fiber per day split into two 10 gram doses administered as a breakfast cereal and a muffin or no-fiber breakfast cereal and muffin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Whole gut transit time determined by radio-opaque pellets
Time Frame: 5 day fecal collection
|
Determine whole gut transit time by x-raying fecal samples after swallowing radio-opaque pellets
|
5 day fecal collection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satiety
Time Frame: 0, 15, 30, 45, 60, 90, 120, 180, 240 minutes postprandially
|
Measure hunger, fullness, satisfaction, and prospective food consumption using a 100 mm line
|
0, 15, 30, 45, 60, 90, 120, 180, 240 minutes postprandially
|
|
Breath Hydrogen concentration after consumption of test cereal
Time Frame: 0 and 240 minutes postprandially
|
Subjects expel air into a storage bag, which is then injected into a gas chromatograph and determine the hydrogen concentration.
Hydrogen gas is an indicator of fermentation in the large intestine.
|
0 and 240 minutes postprandially
|
|
Ad libitum food intake
Time Frame: 24 hours, 48 hours, and 10 days after the start of treatment
|
24 hour food diary
|
24 hours, 48 hours, and 10 days after the start of treatment
|
|
Gastrointestinal Tolerance
Time Frame: 24 hours, 48 hours, and 10 days after the start of the treatment
|
Rank severity of flatuence, bloating, abdominal cramps, stomach noises, nausea, diarrhea, and constipation on a 10 point scale.
|
24 hours, 48 hours, and 10 days after the start of the treatment
|
|
Fecal chemistry
Time Frame: 6-10 days after the start of treatments
|
Determination of fecal pH and short-chain fatty acid concentration
|
6-10 days after the start of treatments
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joanne L Slavin, PhD, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Actual)
April 1, 2010
Study Completion (Actual)
April 1, 2010
Study Registration Dates
First Submitted
March 23, 2010
First Submitted That Met QC Criteria
April 12, 2010
First Posted (Estimate)
April 13, 2010
Study Record Updates
Last Update Posted (Estimate)
September 9, 2010
Last Update Submitted That Met QC Criteria
September 8, 2010
Last Verified
September 1, 2010
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0902M60241
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AkesoNot yet recruitingAtopic DermatitisChina
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States